Case Reports in Dentistry (Jan 2016)

Drug-Induced Hypersensitivity Syndrome Caused by Carbamazepine Used for the Treatment of Trigeminal Neuralgia

  • Yuko Ono,
  • Tsuyoshi Shimo,
  • Yoshinori Shirafuji,
  • Toshihisa Hamada,
  • Masanori Masui,
  • Kyoichi Obata,
  • Mayumi Yao,
  • Koji Kishimoto,
  • Akira Sasaki

DOI
https://doi.org/10.1155/2016/4605231
Journal volume & issue
Vol. 2016

Abstract

Read online

An 88-year-old man was diagnosed with trigeminal neuralgia, and treatment of carbamazepine 200 mg/day was initiated. About 6 weeks later, the patient developed a skin rash accompanied by fever. He was admitted to hospital and diagnosed with drug-induced hypersensitivity syndrome (DIHS) caused by carbamazepine. Oral carbamazepine treatment was stopped, but blood tests showed acute liver and acute renal failure. Drug-induced lymphocyte stimulation test (DLST) for carbamazepine, human herpes virus-6 (HHV-6) IgG, and CMV-HRP were negative. Oral prednisolone therapy was begun 18 days later. The titer of HHV-6 IgG antibodies was then detected (640 times). Following treatment, liver and renal function improved and the erythema disappeared.